Literature DB >> 22126566

The myeloperoxidase-463 G>A polymorphism influences risk of colorectal cancer in southern China: a case-control study.

Ying Li1, Yuan Qin, Mei-Lin Wang, Huan-Feng Zhu, Xin-En Huang.   

Abstract

OBJECTIVE: Oxidative stress may be involved in colorectal carcinogenesis. Myeloperoxidase (MPO) is an endogenous oxidant enzyme that generates reactive oxygen species (ROS). We hypothesized that the MPO -463 locus polymorphism might therefore contribute to genetic susceptibility to colorectal adenomas.
METHODS: RFLP-PCR analysis identified the MPO genotypes in 325 Chinese colorectal adenomas cases and 345 controls matched by age, sex, smoking status, and alcohol use. An epidemiological interview elicited detailed information on demographic data and lifestyle characteristics.
RESULTS: Individuals with a GA/AA genotype had a significantly lower risk of colorectal cancer (adjusted OR = 0.57, 95% CI, 0.41-0.79) than those with the GG genotype. On stratification analysis, the decreased risk was more pronounced among older subjects (adjusted OR = 0.56, 95% CI, 0.39-0.81), males (0.47, 0.33-0.68), smokers (0.54, 0.35-0.85), and ever-drinkers (0.44, 0.27-0.71).
CONCLUSION: For a similar level of exposure to established carcinogens, individuals with MPO A-allele genotypes appear to have a reduced risk of colorectal adenomas in southern Chinese population, especially among older subjects, men, smokers, and ever-drinkers.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22126566

Source DB:  PubMed          Journal:  Asian Pac J Cancer Prev        ISSN: 1513-7368


  2 in total

Review 1.  Association between MPO-463G > A polymorphism and cancer risk: evidence from 60 case-control studies.

Authors:  Wen-Jun Yang; Ming-Yue Wang; Fu-Ze Pan; Chen Shi; Hong Cen
Journal:  World J Surg Oncol       Date:  2017-08-02       Impact factor: 2.754

2.  Proteomic analysis of human cervical adenocarcinoma mucus to identify potential protein biomarkers.

Authors:  Zhifang Ma; Jie Chen; Ting Luan; Chengzhuo Chu; Wangfei Wu; Yichao Zhu; Yun Gu
Journal:  PeerJ       Date:  2020-07-28       Impact factor: 2.984

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.